S0307A, Long-Term Bone Quality in Women With Breast Cancer Enrolled on Clinical Trial SWOG-S0307
Status:
Withdrawn
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Gathering information over time from imaging and laboratory tests of women
receiving bisphosphonates for breast cancer may help doctors learn more about long-term bone
quality and plan the best treatment. Tetracycline hydrochloride and demeclocycline
hydrochloride can mark the new growth of the bone, so it may be seen better under a
microscope.
PURPOSE: This clinical trial is studying long-term bone quality in women with breast cancer
enrolled on clinical trial SWOG-S0307.